| Weight | 1056.404 g/mol |
|---|---|
| Formula | C52H97NO18S |
| Hydrogen Acceptors | 18 |
| Hydrogen Donors | 5 |
| Aromatic Rings | 0 |
| Rotatable Bonds | 21 |
ERYTHROMYCIN ESTOLATE (3521-62-8)
Ilosone · Erythromycin Propionate Dodecyl Sulfate · Erythromycin Propionate Lauryl Sulfate
"What do you need help with?"
LabBot
- Sigma-Aldrich - Search for ERYTHROMYCIN ESTOLATE
- Fisher Scientific - Search for ERYTHROMYCIN ESTOLATE
- TCI - Search for ERYTHROMYCIN ESTOLATE
- Efficacy of Fixed Combination Antibiotics versus Separate Components in Otitis Media Effectiveness of Erythromycin Estolate, Triple Sulfonamide, Ampicillin, Erythromycin Estolate-Triple Sulfonamide, and Placebo in 280 Patients with Acute Otitis Media Under Two and One-Hal Years of Age (Clinical Pediatrics, 1972)
- Azithromycin Is as Effective as and Better Tolerated Than Erythromycin Estolate for the Treatment of Pertussis (Pediatrics, 2004)
- PROTECTIVE ROLE OF TETRAHYDROCURCUMIN AGAINST ERYTHROMYCIN ESTOLATE INDUCED HEPATOTOXICITY (Pharmacological Research, 2004)
- Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. (Antimicrobial Agents and Chemotherapy, 1991)
- Seven Days of Erythromycin Estolate Is as Effective as Fourteen Days for the Treatment of Bordetella pertussis Infections (Pediatrics, 1997)
- Hepatotoxicity of Erythromycin Estolate During Pregnancy (Antimicrobial Agents and Chemotherapy, 1977)
-
Predict GHS Hazards for Any Chemical in silico.
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. - Ilosone
- Erythromycin Propionate Dodecyl Sulfate
- Erythromycin Propionate Lauryl Sulfate
- Erythromycin Propionate Monododecyl Sulfate
- Eromycin
- Lauromicina
-
SMILESCCCCCCCCCCCCOS(=O)(=O)O.CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O
-
InChIKeyAWMFUEJKWXESNL-UHFFFAOYSA-N
- Pubchem - ERYTHROMYCIN ESTOLATE
- Wikipedia - erythromycin estolate
Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn.
Suppliers
Most-cited Publications
Safety
Trends
Alternate Names
External Links
Similar Compounds
Bristamycin
(643-22-1)
7 alternate names
3 suppliers
ERYTHROMYCIN STEARATE
(643-22-1)
7 alternate names
3 suppliers
ERYTHROMYCIN STEARATE
(643-22-1)
7 alternate names
3 suppliers
643-22-1
(643-22-1)
7 alternate names
3 suppliers
erythromycin ethylsuccinate
(1264-62-6)
7 alternate names
3 suppliers
Erythromycin ethyl succinate
(1264-62-6)
7 alternate names
3 suppliers
ST075191
(1264-62-6)
7 alternate names
3 suppliers
1264-62-6
(1264-62-6)
7 alternate names
3 suppliers
1264-62-6
(1264-62-6)
7 alternate names
3 suppliers
Tylosin
(1405-54-5, 1401-69-0)
7 alternate names
3 suppliers
Tylosin
(1405-54-5, 1401-69-0)
7 alternate names
3 suppliers
Tylosin
(1401-69-0)
7 alternate names
3 suppliers
Tylosin
(1401-69-0)
7 alternate names
3 suppliers
Tylosin
(1401-69-0)
7 alternate names
3 suppliers
Tylosin
(1401-69-0)
7 alternate names
3 suppliers
Tylosin
(1401-69-0)
7 alternate names
3 suppliers
Tylosin
(1401-69-0)
7 alternate names
3 suppliers
Tylosin
(1401-69-0)
7 alternate names
3 suppliers
1401-69-0
(1401-69-0)
7 alternate names
3 suppliers
Tylosin A
(1401-69-0)
7 alternate names
3 suppliers
Coxistac
(53003-10-4)
7 alternate names
1 safety hazard
3 suppliers
53003-10-4
(53003-10-4)
7 alternate names
1 safety hazard
3 suppliers
salinomycin
(53003-10-4)
7 alternate names
1 safety hazard
3 suppliers
salinomycin
(53003-10-4)
7 alternate names
1 safety hazard
3 suppliers
salinomycin
(53003-10-4)
7 alternate names
1 safety hazard
3 suppliers
salinomycin
(53003-10-4)
7 alternate names
1 safety hazard
3 suppliers
salinomycin
(53003-10-4)
7 alternate names
1 safety hazard
3 suppliers
salinomycin
(53003-10-4)
7 alternate names
1 safety hazard
3 suppliers
salinomycin
(53003-10-4)
7 alternate names
1 safety hazard
3 suppliers
SUCROSE ACETATE ISOBUTYRATE
(126-13-6)
7 alternate names
3 suppliers
Rifamycin SV
(15105-92-7, 6998-60-3)
7 alternate names
3 suppliers
oleandomycin
(3922-90-5)
7 alternate names
3 suppliers
Spinosyn-A
(131929-60-7)
7 alternate names
1 safety hazard
3 suppliers
oleandomycin
(3922-90-5)
7 alternate names
3 suppliers
oleandomycin
(3922-90-5)
7 alternate names
3 suppliers
oleandomycin
(3922-90-5)
7 alternate names
3 suppliers
oleandomycin
(3922-90-5)
7 alternate names
3 suppliers
oleandomycin
(3922-90-5)
7 alternate names
3 suppliers
Rifadin
(13292-46-1, 62534-43-4)
7 alternate names
3 suppliers
Rifampicin
(13292-46-1, 62534-43-4)
7 alternate names
3 suppliers
Rifampicin
(13292-46-1)
7 alternate names
3 suppliers
Rifampicin
(13292-46-1)
7 alternate names
3 suppliers
Rifampicin
(13292-46-1)
7 alternate names
3 suppliers
rifampin
(13292-46-1)
7 alternate names
3 suppliers
rifampin
(13292-46-1)
7 alternate names
3 suppliers
rifampin
(13292-46-1)
7 alternate names
3 suppliers
Rifampicin
(13292-46-1)
7 alternate names
3 suppliers
Rifampicin
(13292-46-1)
7 alternate names
3 suppliers
Rifaldazin
(13292-46-1)
7 alternate names
3 suppliers
Rifampicin
(13292-46-1)
7 alternate names
3 suppliers
Notoginsenoside R1
(80418-24-2)
7 alternate names
3 suppliers
ERYTHROMYCIN ESTOLATE
CAS Directory
